Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001209191-21-015098

Options or other derivatives

  • President & COO acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bisker-Leib Vered President & COO 2021-02-09 Grant or award · Stock Option (Right to Buy) +400,000 400,000 D
Loading xslF345X03/doc4.xml…